Q3 2022 Bioporto A/S Earnings Call Transcript
Yes, it's 2:00 this afternoon. So welcome to this digital event with BioPorto. My name is Henrik Ekman, and I'm BioTech Equity Analyst here for Andersen Capital. And with me today, I have the pleasure of welcoming the CEO of BioPorto, Tony Pare; and CFO of BioPorto, Neil Goldman.
Before I hand it over to Tony and Neil, just a few remarks. The audience is welcome to post questions in the box, and I will do my best to forward it to the management team. And afterwards, we record this. We will put it on the different media platforms so you can see the event again if you missed something.
So with that, a very warm welcome to 2 of you. I know that your 1-year anniversary Tony, it was yesterday. So a lot of things has happened. And I know you've been very busy in the latest call. So please tell us what the highlights are.
/-
Okay. Thank you. Thank you once again for hosting Henrik and a warm welcome to everyone participating on this Q3 2022 financial results and business update
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |